Recruitment in a randomized, double-blind, placebo-controlled study to assess siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in patients with multicentric Castleman's disease.

Van, Rhee Frits; Capra, Marcelo; Wong, Raymond; Vermeulen, Jessica; Safer, Karim; Todorovic, Marija; Rhoten, Patricia; Van, de Velde Helgi

Results

eNauka > Rezultati > Recruitment in a randomized, double-blind, placebo-controlled study to assess siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in patients with multicentric Castleman's disease.

Naziv:	Recruitment in a randomized, double-blind, placebo-controlled study to assess siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in patients with multicentric Castleman's disease.
Autori:	Van, Rhee Frits; Capra, Marcelo; Wong, Raymond; Vermeulen, Jessica; Safer, Karim; Todorovic, Marija; Rhoten, Patricia; Van, de Velde Helgi
Godina:	2012
Publikacija:	JOURNAL OF CLINICAL ONCOLOGY
ISSN:	0732-183X Journal of Clinical Oncology Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 30 br. 15
WoS-ID:	000318009803834
URI:	https://enauka.gov.rs/handle/123456789/822623
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM